Salesforce.com to B...
Health Care: Health Services
CAS Medical Systems Inc. (CASM: NASDAQ)
$1.92 0.00 | 0.00%
06/04/12 - 09:30 AM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -6.08M | -1.31M | -5.79M | -388.00K |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 71.28K | 1.57M | -629.32K | 654.00K |
| (Increase) Decrease in Inventories | 1.54M | 969.67K | 1.98M | 235.00K |
| (Increase) Decrease In Other Current Assets | 10.57K | 64.36K | 28.79K | 2.00K |
| (Decrease) Increase In Payables | -409.38K | 556.40K | 17.81K | -324.00K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | -66.12K | 121.40K | 11.00K |
| (Increase) Decrease In Other Working Capital | 13.66K | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 493.27K | 79.52K | 2.65M | 435.00K |
| Net Cash From Continuing Operations | -3.60M | 2.53M | 479.78K | 1.66M |
| Net Cash From Discontinued Operations | 366.95K | 940.41K | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -3.24M | 3.47M | 479.78K | 1.66M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.26M | -960.05K | -401.76K | -1.47M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -2.49M | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -3.75M | 2.39M | -401.76K | -1.47M |
| Issuance of Debt | 154.15K | 183.66K | 903.70K | 299.00K |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 13.88M | 2.00M | 84.37K | 1.14M |
| Repayment of Long-Term Debt | -154.15K | -4.61M | -791.18K | -1.20M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -123.22K | -170.76K | -15.00K |
| Net Cash From Financing Activities | 13.88M | -2.55M | 26.14K | 222.00K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 6.89M | 3.31M | 104.16K | 416.00K |
Portfolios with CASM
- Portfolio NameUser Type
- UserAshley
- ContributorUnder-$10 Setting Up To Tra...
- Contributor26 Small-Cap Stocks in Dang...
- Contributor8 Health Care Penny Stocks ...
- Usermsi Portfolio 1
- UserJane's SEP
- Userleon16066 Portfolio 1
- UserAdam Portfolio 1
Latest CASM Headlines from TheStreet
- 5 Stocks Under $10 Poised to Move Higher 04.05.12 | 01:04 pm
- CASMED Reports Fourth Quarter And Full Year 2010 Results 03.02.11 | 08:03 am
- CASMED Announces Fourth Quarter And Year-End 2010 Earnings Release Date And Conference Call Information 02.23.11 | 08:02 am
- CASMED Receives FDA Clearance For Non-Cerebral Indication Of FORE-SIGHT Absolute Tissue Oximeter 01.18.11 | 08:01 am
- CASMED Reports Inducement Grants To VP Of Sales And Marketing Matthew J. Herwig Under NASDAQ Marketplace Rule 5635 01.10.11 | 10:01 am
- CASMED Announces Key Addition To Executive Management Team 01.10.11 | 08:01 am
- CASMED Reports Third Quarter 2010 Results 11.10.10 | 04:11 pm
- CASMED Announces Third Quarter 2010 Earnings Release Date And Conference Call Information 11.03.10 | 08:11 am
- Gregory Rainey Appointed To CASMED Board 11.01.10 | 03:11 pm
- CASMED Announces 9 Scientific Abstracts Demonstrating The Benefits Of FORE-SIGHT Absolute Oximetry 10.21.10 | 08:10 am
Press Releases for CASM
Partner Headlines for CASM
- CASMED Reports Third Quarter EPS of $(0.04) - Benzinga 11.10.10 | 04:11 pm
- UPDATE 1-CAS Medical gets new Japanese patent, shares jump - Reuters 04.13.10 | 10:04 am
